#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in intestine Pleomorphic liposarcoma Vitamin B12 deficiency Scleroderma associated digital ulcer Intracranial calcification Osteosarcoma metastatic Mantle cell lymphoma stage III Erdheim-Chester disease Anal fistula Acute lymphocytic leukaemia recurrent Salivary gland cancer Liver transplant rejection Biotinidase deficiency Langerhans' cell histiocytosis Mantle cell lymphoma More trials…

    Learn about Rare Diseases

    Andersen-Tawil syndrome CADASIL – Treatment Castleman’s disease Chondrosarcoma metastatic – Trials in Disease Hairy cell leukaemia recurrent Short-bowel syndrome – Treatment Marfan’s syndrome – Life with Disease Marfan’s syndrome Primary hyperoxaluria – Life with Disease Primary mediastinal large B-cell lymphoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vorasidenib Lna043 Utreglutide Meloxicam Tranexamic Acid Fludeoxyglucose (18F) ANTI-GD2-800CW Fludarabine Clemastine GSKVX000000046019 Levosimendan VG801-1 Heparin Migalastat Ltp001 Tramadol Balcinrenone Plasma Vibosameran INOBRODIB More therapies…

    Learn about Your Condition

    Choroidal dystrophy Mucosal inflammation Inclusion body myositis Dermatitis Sarcoma Merycism Hypogonadism male B-cell lymphoma recurrent Joint stabilisation Anxiety Mantle cell lymphoma Cirrhosis alcoholic Pelvic venous thrombosis Altered state of consciousness Andersen-Tawil syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study of semaglutide and dapagliflozin effects on heart muscle insulin resistance in patients with type 2 diabetes

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Dapagliflozin Propanediol
    • Semaglutide
    Spain

  • A Study of Migalastat Safety and Effects in Children Aged 2 to 12 Years with Fabry Disease and Suitable Gene Changes

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Fabry’s disease
    Belgium Germany Spain

  • Study of Intradialytic Parenteral Nutrition for Muscle Protein Production in Patients on Long-term Hemodialysis Treatment

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Haemodialysis
    Investigated Drugs:
    • Alanine
    • Arginine
    • ARGININE GLUTAMATE
    The Netherlands

  • Comparison of weekly insulin icodec versus daily basal insulin in adults with type 2 diabetes who have not used insulin before

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • INSULIN DEGLUDEC
    • INSULIN DETEMIR
    • Insulin Glargine
    Germany Italy

  • Study of CMP-CPS-001 injection in healthy volunteers and patients with abnormal ornithine transcarbamylase (OTC) genotype for treating urea cycle disorders

    Not yet recruiting

    1 1
    Investigated Diseases:
    • Urea cycle disorder
    Investigated Drugs:
    • AMMONIUM (15N) CHLORIDE
    • Sodium Acetate (1-13C)
    The Netherlands

  • Study of semaglutide effects on inflammation markers in patients with type 2 diabetes mellitus who have high cardiovascular risk

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Semaglutide
    Italy
Previous Page
1 … 26 27 28 29 30 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!